Dr. Lena Sibulesky, MD

Dr. Sibulesky practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Sibulesky's NPI, 1316014574, was assigned on November 30, 2006. Dr. Sibulesky graduated from Tufts University School of Medicine in 2001. Dr. Sibulesky holds Washington license 60366324.

Dr. Sibulesky's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Sibulesky's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Dr. Sibulesky to 1 more hospital, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sibulesky practices, 3 sites in all. Vendor and product names are available with a free account.

Transplant surgery is Dr. Sibulesky's primary specialty in the NPI Registry, under taxonomy code 204F00000X. Dr. Sibulesky is licensed in Washington.

CMS data shows 254 Medicare services from Dr. Sibulesky across 6 procedure codes in 2024, for 127 Medicare patients. Medicare paid $85,450 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 127 Medicare patients who saw Dr. Sibulesky in 2024. The largest group is under 65, with 59 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 32% are also on Medicaid. Their average risk score is 6.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sibulesky's median patient age at 55, with 42% women.

In 2024, Dr. Sibulesky wrote 298 Medicare Part D claims for 47 patients. 87% of them were for generic drugs. CMS names the drug for 154 of them, across 8 drugs with 11 or more claims each, at $15,352 in total drug cost. In 2023, CMS named 325 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Sibulesky for performance year 2024, reported through an alternative payment model (APM). Dr. Sibulesky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 57 papers to Dr. Sibulesky, published from 2012 to 2025. 2018 was the busiest year, with 7. The most frequent topics are Kidney Transplantation, Tissue Donors and Tissue and Organ Procurement. Dr. Sibulesky has published most often in Am J Transplant. Dr. Sibulesky's most frequent co-authors are James D. Perkins, Nicolae Leca and Ramasamy Bakthavatsalam.

CMS Open Payments shows 2 general payments to Dr. Sibulesky from 2 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 91% of the total. Sanofi and Genzyme US Companies paid the most, $125. It also lists 2 research payments totaling $601 in 2017.

Dr. Sibulesky graduated from Tufts University School of Medicine in 2001.